Stock Earnings

Question 1

Altimmune Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Altimmune Inc'in toplam varlıkları $139 olup, net loss $-95'dir.

Question 2

ALT'ün temel finansal oranları nelerdir?

Accepted Answer

Altimmune Inc'in cari oranı 9.26, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Altimmune Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Altimmune Inc largest revenue segment is Treatments for Various Diseases and Disorders, and Vaccines, at a revenue of 20,000 in the most earnings release.For geography, United States is the primary market for Altimmune Inc, at a revenue of 20,000.

Question 4

Altimmune Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Altimmune Inc'in net loss $-95'dir.

Question 5

Altimmune Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Altimmune Inc'in yükümlülüğü 15'dir.

Question 6

Altimmune Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Altimmune Inc'in toplam tedavüldeki hisse sayısı 72.35'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	4	8
Revenue Growth (YoY)	--	--	--	-100%	-50%	60%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	21	20	18	17	15	13
Research & Development	72	82	65	70	74	49
Operating Expenses	94	103	83	87	89	62
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-88	-95	-88	-84	-97	-54
Income Tax Expense	--	0	0	0	0	-5
Net Income	-87	-95	-88	-84	-97	-49
Net Income Growth	-14%	8%	5%	-13%	98%	145%
Shares Outstanding (Diluted)	81.47	71	53.24	46.93	41.28	25.64
Shares Change (YoY)	15%	33%	13%	14%	61%	95%
EPS (Diluted)	-1.07	-1.33	-1.66	-1.81	-2.35	-1.91
EPS Growth	-25%	-19%	-8%	-23%	23%	19%
Free Cash Flow	-81	-79	-75	-62	-90	-34
Free Cash Flow Per Share	-0.99	-1.11	-1.4	-1.32	-2.18	-1.32
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-2,125%	-675%
Profit Margin	0%	0%	0%	0%	-2,425%	-612.5%
Free Cash Flow Margin	0%	0%	0%	0%	-2,250%	-425%
EBITDA	-94	-103	-83	--	-85	-54
EBITDA Margin	0%	0%	0%	--	-2,125%	-675%
D&A For EBITDA	0	0	0	--	0	0
EBIT	-94	-103	-83	-87	-85	-54
EBIT Margin	0%	0%	0%	0%	-2,125%	-675%
Effective Tax Rate	--	0%	0%	0%	0%	9.25%

Altimmune Inc (ALT) Price

ALT Stock Price Chart

ALT Income

Follow-Up Questions